At a glance
ClinicalIndex Comparison RecordN/ACompleted· 376 enrolled
Drug / intervention
Radiofrequency Ablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Prospective Clinical Evaluation of the DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation
In Brief
A clinical study evaluating Radiofrequency Ablation for Persistent Atrial Fibrillation and Atrial Fibrillation. Completed, enrolled 376 participants across 28 sites in 6 countries.
Detailed Summary
The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada, Czechia, France, Germany, Italy, United States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2018
Enrollment StartSep 2018
Primary CompletionOct 2024
TodayJul 2026
First PostedAug 22, 2018
Enrollment StartSep 19, 2018
Primary CompletionOct 31, 2024
TodayJul 2, 2026
Enrollment to primary: 6.1 yearsPosted 7.9 years ago
Interventions
Radiofrequency Ablationdevice
A procedure will be performed using a radiofrequency ablation catheter.